aurora-2 kinase inhibitors (Ambit)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameaurora-2 kinase inhibitors (Ambit)
Drug Alias NameAB-038
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Aurora-A inhibitors
TargetsSerine/threonine-protein kinase Aurora-A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmbit Biosciences Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmbit Biosciences Co
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A